Malady Kyle

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 24% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Malady Kyle's trades of DexCom Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-09 2025-09-05
US DexCom Inc (DXCM)
PlS Planned sale
63,867 +39.5%
149.84
US$348,414 		63,867 +39.5% 149.84 US$348,414
2025-09-05 2025-09-05
US DexCom Inc (DXCM)
PrS Proposed sale
61,502
390.60
US$4,911,951 		61,502 390.60 US$4,911,951
2025-05-09 2025-05-08
S Sale
4,498 +31.7%
101.14
US$12,817 		4,498 +31.7% 101.14 US$12,817
2025-05-09 2025-05-08
S Sale
9,701 -96.9%
43.81
US$425,001 		9,701 -96.9% 43.81 US$425,001
2025-05-08 2025-05-08
PrS Proposed sale
10,000
43.81
US$438,102 		10,000 43.81 US$438,102
2025-05-08 2025-05-07
S Sale
9,000 -47.3%
44.10
US$396,900 		9,000 -47.3% 44.10 US$396,900
2025-05-07 2025-05-07
PrS Proposed sale
9,000
44.10
US$396,901 		9,000 44.10 US$396,901
2025-05-01 2025-04-30
S Sale
7,500 -28.3%
43.88
US$329,062 		7,500 -28.3% 43.88 US$329,062
2025-04-30 2025-04-30
PrS Proposed sale
7,500
43.88
US$329,062 		7,500 43.88 US$329,062
2025-04-25 2025-04-24
S Sale
10,000 -27.4%
43.02
US$430,240 		10,000 -27.4% 43.02 US$430,240
2025-04-24 2025-04-24
PrS Proposed sale
10,000
43.02
US$430,240 		10,000 43.02 US$430,240
2025-04-24 2025-04-23
S Sale
5,000 -12.0%
42.49
US$212,425 		5,000 -12.0% 42.49 US$212,425
2025-04-23 2025-04-23
PrS Proposed sale
5,000
42.49
US$212,425 		5,000 42.49 US$212,425
2025-02-06 2025-02-04
S Sale
6,590 -100.0%
39.70
US$261,623 		6,590 -100.0% 39.70 US$261,623
2025-02-04 2025-02-04
PrS Proposed sale
6,590
39.70
US$261,624 		6,590 39.70 US$261,624
2025-02-05 2025-02-03
S Sale
8,000 -54.8%
39.89
US$319,080 		8,000 -54.8% 39.89 US$319,080
2025-02-03 2025-02-03
PrS Proposed sale
8,000
39.89
US$319,080 		8,000 39.89 US$319,080
2025-01-31 2025-01-29
S Sale
11,085 -43.2%
40.88
US$453,155 		11,085 -43.2% 40.88 US$453,155
2025-01-29 2025-01-29
PrS Proposed sale
11,085
40.88
US$453,155 		11,085 40.88 US$453,155
2025-01-30 2025-01-28
S Sale
20,000 -43.8%
40.49
US$809,800 		20,000 -43.8% 40.49 US$809,800
2025-01-28 2025-01-28
PrS Proposed sale
20,000
40.49
US$809,803 		20,000 40.49 US$809,803
2025-01-29 2025-01-27
S Sale
20,000 -30.5%
40.54
US$810,800 		20,000 -30.5% 40.54 US$810,800
2025-01-27 2025-01-27
PrS Proposed sale
10,000
40.72
US$407,223 		10,000 40.72 US$407,223
2025-01-27 2025-01-27
PrS Proposed sale
10,000
40.35
US$403,493 		10,000 40.35 US$403,493
2025-01-27 2025-01-27
PrS Proposed sale
10,000
40.35
US$403,493 		10,000 40.35 US$403,493
2024-02-26 2024-02-22
S Sale
24,000 -40.5%
40.80
US$979,200 		24,000 -40.5% 40.80 US$979,200
2024-02-22 2024-02-22
PrS Proposed sale
24,000
40.80
US$979,095 		24,000 40.80 US$979,095
2024-02-20 2024-02-15
S Sale
15,000 -20.2%
40.33
US$604,950 		15,000 -20.2% 40.33 US$604,950
2024-02-15 2024-02-15
PrS Proposed sale
15,000
40.33
US$604,953 		15,000 40.33 US$604,953
2023-03-17 2023-03-15
PlS Planned sale
6,226 -8.4%
36.69
US$228,432 		6,226 -8.4% 36.69 US$228,432
2023-03-15 2023-03-15
PrS Proposed sale
6,226
36.69
US$228,432 		6,226 36.69 US$228,432
2023-03-15 2023-03-14
PlS Planned sale
7,546 -9.2%
36.74
US$277,240 		7,546 -9.2% 36.74 US$277,240
2023-03-14 2023-03-14
PrS Proposed sale
7,546
36.74
US$277,240 		7,546 36.74 US$277,240
2023-03-15 2023-03-13
PlS Planned sale
7,199 -8.1%
36.50
US$262,764 		7,199 -8.1% 36.50 US$262,764
2023-03-13 2023-03-13
PrS Proposed sale
7,199
36.50
US$262,764 		7,199 36.50 US$262,764